P593 Ustekinumab for the treatment of perianal Crohn’s disease. A real-world experience in a Spanish hospital

MLA

A Masedo Gonzalez, et al. “P593 Ustekinumab for the Treatment of Perianal Crohn’s Disease. A Real-World Experience in a Spanish Hospital.” Journal of Crohn’s and Colitis, vol. 15, May 2021, p. S542. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........fe419de4fd7cdb7a6e8660a1cb8ae28b&authtype=sso&custid=ns315887.

APA

A Masedo Gonzalez, C Yela San Bernardino, B Casis Herce, G J Gomez Gomez, M Algara San Nicolas, & M P Martinez Montiel. (2021). P593 Ustekinumab for the treatment of perianal Crohn’s disease. A real-world experience in a Spanish hospital. Journal of Crohn’s and Colitis, 15, S542.

Chicago

A Masedo Gonzalez, C Yela San Bernardino, B Casis Herce, G J Gomez Gomez, M Algara San Nicolas, and M P Martinez Montiel. 2021. “P593 Ustekinumab for the Treatment of Perianal Crohn’s Disease. A Real-World Experience in a Spanish Hospital.” Journal of Crohn’s and Colitis 15 (May): S542. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........fe419de4fd7cdb7a6e8660a1cb8ae28b&authtype=sso&custid=ns315887.